Earnings History Data for Tempest Therapeutics, Inc. (TPST) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Tempest Therapeutics, Inc.

Tempest Therapeutics Inc. is a clinical-stage oncology company developing potentially first-in-class therapeutics which combines both targeted and immune-mediated mechanisms. Tempest Therapeutics Inc., formerly known as Millendo Therapeutics Inc., is based in Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	AH		TPST	Tempest Therapeutics	27.00	-0.41	-0.37	0.00	Tempest Therapeutics GAAP EPS of -$0.41 misses by $0.05 [11/12/2024 5:49 PM]	0.9666	-0.11 (-10.50%)	0.97	-0.11 (-10.33%)	0.86 - 6.00	2,486,338	2,920,000	643,593
Tempest Therapeutics GAAP EPS of -$0.41 misses by $0.05 [11/12/2024 5:49 PM] Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update [2024-11-12 04:21PM] Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma [2024-11-12 08:00AM]
08-08-2024	PM		TPST	Tempest Therapeutics, Inc.	33.99	-0.42	-0.47	-0.54	Tempest Therapeutics GAAP EPS of -$0.42 misses by $0.02 [8/9/2024 3:05 AM]	1.16	-0.18 (-13.43%)	1.37	0.03 (2.24%)	0.17 - 9.77	1,112,338	540,000	1,674
Tempest Therapeutics GAAP EPS of -$0.42 misses by $0.02 [8/9/2024 3:05 AM]
19-03-2024	AH		TPST	Tempest Therapeutics	70.00	-0.34	-0.38	0.00	Tempest Therapeutics GAAP EPS of -$1.91 beats by $0.03 [3/19/2024 4:37 PM]	3.73	-0.01 (-0.27%)	3.80	0.06 (1.60%)	0.17 - 9.77	760,880	680,000	39,012
Tempest Therapeutics GAAP EPS of -$1.91 beats by $0.03 [3/19/2024 4:37 PM]
08-11-2023	AH		TPST	Tempest Therapeutics	41.00	-0.48	-0.55	0.00	Tempest Therapeutics GAAP EPS of -$0.48 beats by $0.09 [11/8/2023 6:04 PM]	3.28	0.46 (16.31%)	3.46	0.64 (22.70%)	0.17 - 9.77	54,707,073	2,720,000	1,196,417
Tempest Therapeutics GAAP EPS of -$0.48 beats by $0.09 [11/8/2023 6:04 PM] Tempest Therapeutics stock rallies in wake of business update [11/9/2023 1:24 PM]
10-08-2023	PM		TPST	Tempest Therapeutics	7.00	-0.54	-0.58	0.00	Tempest Therapeutics GAAP EPS of -$0.54 misses by $0.06 [8/11/2023 4:27 AM]	0.62	0.01 (1.64%)	0.62	0.01 (1.64%)	0.54 - 4.21	195,323	220,000	13,789
Tempest Therapeutics GAAP EPS of -$0.54 misses by $0.06 [8/11/2023 4:27 AM]
10-05-2023	AH	After the close (May 10)	TPST	Tempest Therapeutics	22.00	-0.55	-0.66	0.00	Tempest Therapeutics GAAP EPS of -$0.55 beats by $0.07 [5/10/2023 5:28 PM]	2.13	0.07 (3.40%)	1.98	-0.08 (-3.88%)	1.06 - 4.21	53,399	1,310,000	1,452
Tempest Therapeutics GAAP EPS of -$0.55 beats by $0.07 [5/10/2023 5:28 PM]
22-03-2023	AH		TPST	Tempest Therapeutics	13.00	-0.63	-0.72	0.00	Tempest Therapeutics GAAP EPS of -$3.09 beats by $0.43 [3/22/2023 5:32 PM]	1.40	0.09 (6.52%)	1.43	0.12 (8.80%)	1.06 - 4.55	11,696	10,000	949
Tempest Therapeutics GAAP EPS of -$3.09 beats by $0.43 [3/22/2023 5:32 PM]
15-08-2022	PM		TPST	Tempest Therapeutics	24.00	-0.79	-0.92	0.00	Tempest Therapeutics GAAP EPS of -$0.79 [8/15/2022 8:32 AM]	2.46	0.32 (14.65%)	2.18	0.03 (1.40%)	2.00 - 16.39	71,168	20,000	561
Tempest Therapeutics GAAP EPS of -$0.79 [8/15/2022 8:32 AM]
13-05-2022	PM		TPST	Tempest Therapeutics	20.00	-1.18	-1.12	0.00	Tempest Therapeutics GAAP EPS of -$1.18 misses by $0.06 [5/13/2022 8:35 AM]	2.89	0.17 (6.25%)	0.0	0.0 (0.00%)	2.16 - 41.00	114,155	300,000	0
Tempest Therapeutics GAAP EPS of -$1.18 misses by $0.06 [5/13/2022 8:35 AM] Tempest Reports First Quarter 2022 Financial Results and Provides Corporate Highlights [May-13-22 08:00AM]
29-03-2022	AH	4:05 PM ET (Mar 29)	TPST	Tempest Therapeutics, Inc.	27.23	N/A	-1.22	0.00	Tempest Therapeutics GAAP EPS of -$7.47 [3/29/2022 4:51 PM]	3.50	-0.30 (-7.89%)	3.96	0.16 (4.21%)	2.16 - 41.00	6,972	40,000	300
Tempest Therapeutics GAAP EPS of -$7.47 [3/29/2022 4:51 PM] Tempest Reports Year End 2021 Financial Results and Provides Business Update [Mar-29-22 04:00PM]
10-11-2021	AH		TPST	Tempest Therapeutics	80.00	-1.21	-1.05	0.00	Tempest Therapeutics reports Q3 results [11/10/2021 4:48 PM]	11.78	0.12 (1.03%)	0.0	0.0 (0.00%)	10.38 - 41.55	7,574	10,000	0
Tempest Therapeutics reports Q3 results [11/10/2021 4:48 PM] Tempest Reports Third Quarter 2021 Financial Results and Provides Corporate Highlights [Nov-10-21 04:05PM] Tempest to Present at Two Upcoming Investor Conferences in November [Nov-09-21 08:00AM]
12-08-2021	AH		TPST	Tempest Therapeutics, Inc.	17.00	-7.63	-0.88	0.00	Tempest Therapeutics reports Q2 results [8/12/2021 5:08 PM]	13.19	-0.54 (-3.93%)	13.45	-0.28 (-2.04%)	10.38 - 41.55	103,677	250,000	130
Tempest Therapeutics reports Q2 results [8/12/2021 5:08 PM] Tempest Reports Second Quarter 2021 Financial Results and Provides Corporate Highlights [Aug-12-21 04:01PM]